Cargando…

Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis

KBP-7018 is a novel selective tyrosine kinase inhibitor with potential for the treatment of idiopathic pulmonary fibrosis. The objective of this study was to characterize the preclinical pharmacokinetics of KBP-7018 in vitro and in vivo, and then to assess the likelihood of developing KBP-7018 as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhenhua, Li, Heran, Zhang, Qian, Tan, Xiaojuan, Lu, Fangzheng, Liu, Hongzhuo, Li, Sanming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532346/ https://www.ncbi.nlm.nih.gov/pubmed/26273193 http://dx.doi.org/10.2147/DDDT.S83055

Ejemplares similares

Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo
por: Wang, Ping, et al.
Publicado: (2023)

Nonclinical Pharmacokinetics, Protein Binding, and Elimination of KBP-7072, an Aminomethylcycline Antibiotic, in Animal Models
por: Tan, Xiaojuan, et al.
Publicado: (2020)

Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide
por: Li, Heran, et al.
Publicado: (2017)

Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis
por: Schmid, Ulrike, et al.
Publicado: (2017)

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
por: Han, Renru, et al.
Publicado: (2022)

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents
por: Ananthula, Hari Krishna, et al.
Publicado: (2018)

Upregulation of receptor tyrosine kinase-like orphan receptor 2 in idiopathic pulmonary fibrosis
por: Son, Ji-Hye, et al.
Publicado: (2021)

SH3KBP1 Promotes Glioblastoma Tumorigenesis by Activating EGFR Signaling
por: Song, Hai, et al.
Publicado: (2021)

A Novel 90-kbp Deletion of RUNX2 Associated with Cleidocranial Dysplasia
por: Zhang, Yanli, et al.
Publicado: (2022)

Enhanced Bruton’s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis
por: Heukels, Peter, et al.
Publicado: (2019)

The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein
por: Wozniak, Marcin J, et al.
Publicado: (2005)

Multiple Functions of KBP in Neural Development Underlie Brain Anomalies in Goldberg-Shprintzen Syndrome
por: Chang, Hsin-Yun, et al.
Publicado: (2019)

OpenKBP-Opt: an international and reproducible evaluation of 76 knowledge-based planning pipelines
por: Babier, Aaron, et al.
Publicado: (2022)

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells
por: Jiang, Yuelong, et al.
Publicado: (2022)

KBP interacts with SCG10, linking Goldberg–Shprintzen syndrome to microtubule dynamics and neuronal differentiation
por: Alves, Maria M., et al.
Publicado: (2010)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
por: Saronni, Davide, et al.
Publicado: (2022)

1389. Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model Against S. aureus (SA) and S. pneumoniae (SPN)
por: Lepak, Alexander J, et al.
Publicado: (2018)

The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
por: Kathawala, Rishil J., et al.
Publicado: (2014)

Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis
por: Liu, Feng, et al.
Publicado: (2016)

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis
por: Amano, Hideki, et al.
Publicado: (2021)

Role of Kif15 and its novel mitotic partner KBP in K-fiber dynamics and chromosome alignment
por: Brouwers, Nathalie, et al.
Publicado: (2017)

Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility
por: Hu, Beibei, et al.
Publicado: (2020)

Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor
por: Wang, Jiayu, et al.
Publicado: (2018)

Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022)

Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
por: Roesler, Rafael, et al.
Publicado: (2021)

The 203 kbp Mitochondrial Genome of the Phytopathogenic Fungus Sclerotinia borealis Reveals Multiple Invasions of Introns and Genomic Duplications
por: Mardanov, Andrey V., et al.
Publicado: (2014)

Candidate genes of idiopathic pulmonary fibrosis: current evidence and research
por: Zhou, Wei, et al.
Publicado: (2016)

Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?
por: Qu, Kai, et al.
Publicado: (2016)

Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer
por: Pozo, Karine, et al.
Publicado: (2018)

Bruton’s Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials
por: Rozkiewicz, Dariusz, et al.
Publicado: (2023)

Preclinical pharmacokinetics of benznidazole.
por: Workman, P., et al.
Publicado: (1984)

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
por: James, Angela Joubert, et al.
Publicado: (2020)

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
por: Jing, Shan, et al.
Publicado: (2023)

The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
por: Jaisser, Frédéric, et al.
Publicado: (2021)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022)

Implementation, Dosimetric Assessment, and Treatment Validation of Knowledge-Based Planning (KBP) Models in VMAT Head and Neck Radiation Oncology
por: Fanou, Anna-Maria, et al.
Publicado: (2023)

Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis
por: Wang, Yunguan, et al.
Publicado: (2020)

Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary Fibrosis
por: Cui, Yu, et al.
Publicado: (2021)

Pneumothorax triggered by EGFR‐tyrosine kinase inhibitors in three microwave ablation candidates: A review of the literature
por: Guo, Runqi, et al.
Publicado: (2020)

The Tyrosine Kinase Inhibitor Sunitinib Affects Ovulation but Not Ovarian Reserve in Mouse: A Preclinical Study
por: Bernard, Valérie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_urt7snta6jck0tgq0qevjtanbt